CS219885B2 - Method of making the n-lallyl-2-pyrolidylmethyl/-2,3-dimethoxy-5-sulphamoylbenzamide - Google Patents

Method of making the n-lallyl-2-pyrolidylmethyl/-2,3-dimethoxy-5-sulphamoylbenzamide Download PDF

Info

Publication number
CS219885B2
CS219885B2 CS774811A CS481177A CS219885B2 CS 219885 B2 CS219885 B2 CS 219885B2 CS 774811 A CS774811 A CS 774811A CS 481177 A CS481177 A CS 481177A CS 219885 B2 CS219885 B2 CS 219885B2
Authority
CS
Czechoslovakia
Prior art keywords
dimethoxy
allyl
compound
group
sulfamoylbenzamide
Prior art date
Application number
CS774811A
Other languages
Czech (cs)
English (en)
Inventor
Michel L Thominet
Jacques Perrot
Original Assignee
Scientif Et Ind De L Ille De F
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scientif Et Ind De L Ille De F filed Critical Scientif Et Ind De L Ille De F
Publication of CS219885B2 publication Critical patent/CS219885B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CS774811A 1976-07-19 1977-07-19 Method of making the n-lallyl-2-pyrolidylmethyl/-2,3-dimethoxy-5-sulphamoylbenzamide CS219885B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7622180A FR2358892A1 (fr) 1976-07-19 1976-07-19 N(1'-allyl 2'-pyrrolidylmethyl)2,3-dimethoxy 5-sulfamoyl benzamide, ses derives

Publications (1)

Publication Number Publication Date
CS219885B2 true CS219885B2 (en) 1983-03-25

Family

ID=9175947

Family Applications (1)

Application Number Title Priority Date Filing Date
CS774811A CS219885B2 (en) 1976-07-19 1977-07-19 Method of making the n-lallyl-2-pyrolidylmethyl/-2,3-dimethoxy-5-sulphamoylbenzamide

Country Status (38)

Country Link
US (1) US4499019A (US06252093-20010626-C00008.png)
JP (1) JPS5338631A (US06252093-20010626-C00008.png)
AR (1) AR214330A1 (US06252093-20010626-C00008.png)
AT (1) AT365570B (US06252093-20010626-C00008.png)
AU (1) AU509291B2 (US06252093-20010626-C00008.png)
BE (1) BE856289A (US06252093-20010626-C00008.png)
CH (1) CH627162A5 (US06252093-20010626-C00008.png)
CS (1) CS219885B2 (US06252093-20010626-C00008.png)
CY (1) CY1036A (US06252093-20010626-C00008.png)
DD (2) DD132492A5 (US06252093-20010626-C00008.png)
DK (1) DK156646C (US06252093-20010626-C00008.png)
EG (1) EG12911A (US06252093-20010626-C00008.png)
ES (1) ES460621A1 (US06252093-20010626-C00008.png)
FI (1) FI67213C (US06252093-20010626-C00008.png)
FR (1) FR2358892A1 (US06252093-20010626-C00008.png)
GB (1) GB1539319A (US06252093-20010626-C00008.png)
GR (1) GR60836B (US06252093-20010626-C00008.png)
HK (1) HK17880A (US06252093-20010626-C00008.png)
HU (1) HU174981B (US06252093-20010626-C00008.png)
IE (1) IE46171B1 (US06252093-20010626-C00008.png)
IL (1) IL52547A (US06252093-20010626-C00008.png)
IN (1) IN146993B (US06252093-20010626-C00008.png)
LU (1) LU77782A1 (US06252093-20010626-C00008.png)
MC (1) MC1153A1 (US06252093-20010626-C00008.png)
MX (1) MX4711E (US06252093-20010626-C00008.png)
NL (1) NL174347C (US06252093-20010626-C00008.png)
NO (1) NO146598C (US06252093-20010626-C00008.png)
NZ (1) NZ184634A (US06252093-20010626-C00008.png)
OA (1) OA05704A (US06252093-20010626-C00008.png)
PH (1) PH12838A (US06252093-20010626-C00008.png)
PL (1) PL104244B1 (US06252093-20010626-C00008.png)
PT (1) PT66819B (US06252093-20010626-C00008.png)
RO (1) RO71691A (US06252093-20010626-C00008.png)
SE (1) SE425243B (US06252093-20010626-C00008.png)
SU (1) SU695556A3 (US06252093-20010626-C00008.png)
YU (1) YU40677B (US06252093-20010626-C00008.png)
ZA (1) ZA774256B (US06252093-20010626-C00008.png)
ZM (1) ZM5477A1 (US06252093-20010626-C00008.png)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2438650A1 (fr) * 1978-10-11 1980-05-09 Ile De France N-(1-methyl 2-pyrrolidinyl methyl) 2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives, leurs methodes de preparation et leur application dans le traitement des troubles du bas appareil urinaire
JPS5639431A (en) * 1979-09-06 1981-04-15 Susumu Yagyu Colorimeter having two-light pass length and two-wave length
FR2478093A1 (fr) * 1980-03-12 1981-09-18 Ile De France Nouveau procede de preparation de n-(1-alkyl (ou allyl) 2-pyrrolidinyl-methyl)2-methoxy (ou 2,3-dimethoxy) 5-sulfamoyl (ou sulfamoyl substitue)
FR2550447B1 (fr) * 1983-08-10 1986-01-17 Ile De France Application du n-(ally-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide comme antiagregant plaquettaire
FR2584605B1 (fr) * 1985-07-15 1988-06-17 Ile De France Application du n-(1-allyl-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide dans le traitement de la maladie de parkinson
US7645750B2 (en) * 2006-12-13 2010-01-12 Yung Shin Pharmaceutical Ind. Co., Ltd. Method of treating symptoms of hormonal variations
US8420624B2 (en) * 2007-12-04 2013-04-16 Yung Shin Pharm. Ind. Co., Ltd. Methods for treating or preventing symptoms of hormonal variations
CN105481733A (zh) * 2015-12-30 2016-04-13 苏州诚和医药化学有限公司 一种一步法合成2-甲氧基-5-氨磺酰基苯甲酸甲酯的方法

Also Published As

Publication number Publication date
US4499019A (en) 1985-02-12
IE46171L (en) 1978-01-19
SE425243B (sv) 1982-09-13
DK156646B (da) 1989-09-18
AU509291B2 (en) 1980-05-01
CH627162A5 (US06252093-20010626-C00008.png) 1981-12-31
DK156646C (da) 1990-02-05
LU77782A1 (US06252093-20010626-C00008.png) 1977-10-17
ZA774256B (en) 1978-06-28
PT66819A (fr) 1977-08-01
PT66819B (fr) 1978-12-22
SE7708176L (sv) 1978-01-20
MX4711E (es) 1982-08-11
ZM5477A1 (en) 1978-05-22
NO146598B (no) 1982-07-26
EG12911A (en) 1980-12-31
FR2358892B1 (US06252093-20010626-C00008.png) 1978-12-15
PL199723A1 (pl) 1978-04-24
HU174981B (hu) 1980-04-28
NL174347C (nl) 1984-06-01
SU695556A3 (ru) 1979-10-30
IN146993B (US06252093-20010626-C00008.png) 1979-10-20
ATA511677A (de) 1981-06-15
MC1153A1 (fr) 1978-04-17
IL52547A0 (en) 1977-10-31
AR214330A1 (es) 1979-05-31
NL174347B (nl) 1984-01-02
NO772530L (no) 1978-01-20
IL52547A (en) 1980-01-31
HK17880A (en) 1980-04-11
FI772214A (US06252093-20010626-C00008.png) 1978-01-20
CY1036A (en) 1980-08-01
DD132492A5 (de) 1978-10-04
IE46171B1 (en) 1983-03-23
YU40677B (en) 1986-04-30
NO146598C (no) 1982-11-03
AT365570B (de) 1982-01-25
AU2702677A (en) 1979-01-18
PH12838A (en) 1979-09-05
GR60836B (en) 1978-08-31
FI67213C (fi) 1985-02-11
DK326377A (da) 1978-01-20
OA05704A (fr) 1981-05-31
BE856289A (fr) 1977-12-30
YU173977A (en) 1983-01-21
GB1539319A (en) 1979-01-31
JPS5338631A (en) 1978-04-08
FR2358892A1 (fr) 1978-02-17
DD137670A5 (de) 1979-09-19
NZ184634A (en) 1978-11-13
NL7707982A (nl) 1978-01-23
FI67213B (fi) 1984-10-31
PL104244B1 (pl) 1979-08-31
ES460621A1 (es) 1978-05-01
RO71691A (ro) 1982-09-09
JPS554724B2 (US06252093-20010626-C00008.png) 1980-01-31

Similar Documents

Publication Publication Date Title
SE457081B (sv) 1,2-diaminocyklobutan-3,4-dioner, foerfarande foer framstaellning av dessa, mellanprodukt och en farmaceutisk komposition
JPH0662568B2 (ja) 新規化合物、その調製方法および筋肉弛緩剤としての使用
EP0047923B1 (de) Isochinolinderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
IE44280B1 (en) 2,3-dihydro-imidazo/2,1-b-thiazole derivatives and process for their preparation
JPH0428269B2 (US06252093-20010626-C00008.png)
CS219885B2 (en) Method of making the n-lallyl-2-pyrolidylmethyl/-2,3-dimethoxy-5-sulphamoylbenzamide
JPS62145049A (ja) アミノスチリル化合物及びそれを有効成分とするロイコトリエンきつ抗剤
US3265691A (en) 1-benzyl-2-aminomethyl-5, 6-dialkoxybenzimidazoles
DE3233424A1 (de) Isochinolinderivate, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
HUT70174A (en) New 3-phenyl-sulphonyl-3,7-diazabicyclo [3.3.1] nonane compounds and pharmaceutical compounds containing the same
EP0099122B1 (en) Compositions comprising pepstatin and an histamine h2-receptor antagonist having an enhanced antiulcer activity
PT100216B (pt) N-{{4,5-di-hidroxi- e 4,5,8-tri-hidroxi-9,10-di-hidro-9,10-dioxo-2-antracentil} carbonil}-aminoacidos uteis na terapia de afeccoes osteoarticulares, processo para a sua preparacao e composicoes farmaceuticas que os contem
JPS60158190A (ja) ヒダントイン誘導体およびその製法ならびにそれを含有する医薬
CS221527B2 (en) Method of preparation of n-/1-methyl-2-pyrrolidinylmethyl/2,3-dimethoxy-5-methylsulphamoylbenzamide
SK278141B6 (en) Enolether amide 1,1-dioxo-6-chloro-4-hydroxy-2-methyl-n- -(2-pyridyl)-2h-thieno(2,3-e)1,2-thiazine-3-carboxylic acid, method of its production and pharmaceutical agent
US3005818A (en) 1-phenyl-2, 3-dimethyl-4-morpholino methyl pyrazolone-(5) compounds
IE45144B1 (en) Aminoalkyl esters of carbamimidothioic acid and compositions having immunosuppressant activity
US3586675A (en) Fused thiazines
DE2734270C2 (US06252093-20010626-C00008.png)
JPS63227570A (ja) イソキノリン誘導体
CS208658B2 (en) Method of makingthe derivatives of the 3-amino-17aaza-d-homo-5alfaandrostane
US4100287A (en) Pyrimidine derivative
CS208131B2 (en) Method of making the new derivatives of the 1,3-benzoxazine-2,4-dione
US4853415A (en) 2-(substituted sulfamyl) derivatives of 4-nitrobenzamide as radiation sensitizers
KR800001180B1 (ko) N-(1′-알릴-2′-피롤리딜메틸)-2,3-디메톡시-5-설파모일벤즈아미드의 제조방법